Comparative Pharmacology
Head-to-head clinical analysis: METHADOSE versus PROMETH HYDROCHLORIDE PHENYLEPHRINE HYDROCHLORIDE W CODEINE PHOSPHATE.
Peer-Reviewed Evidence
Head-to-head clinical analysis: METHADOSE versus PROMETH HYDROCHLORIDE PHENYLEPHRINE HYDROCHLORIDE W CODEINE PHOSPHATE.
METHADOSE vs PROMETH HYDROCHLORIDE,PHENYLEPHRINE HYDROCHLORIDE W/CODEINE PHOSPHATE
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Methadone is a mu-opioid receptor agonist; it also acts as an NMDA receptor antagonist and inhibits serotonin and norepinephrine reuptake, contributing to its analgesic and detoxification effects. It has a long half-life and reduces opioid craving and withdrawal symptoms.
Promethazine is a phenothiazine derivative that acts as a histamine H1 receptor antagonist, anticholinergic, and antiemetic; phenylephrine is an alpha-1 adrenergic receptor agonist causing vasoconstriction; codeine is an opioid agonist at mu-opioid receptors, producing analgesia and antitussive effects.
Oral: 20-40 mg once daily, titrated to effect; for opioid dependence, typical maintenance 80-120 mg/day. IV: 2.5-10 mg every 8-12 hours.
Promethazine 6.25 mg/phenylephrine 5 mg/codeine 10 mg per 5 mL oral solution: 5 mL every 4 hours as needed; max 30 mL/day.
None Documented
None Documented
Terminal elimination half-life range: 8–59 hours (mean ~20–35 hours). In chronic use, half-life may increase due to accumulation. Context: The long half-life supports once-daily dosing for opioid dependence but requires careful titration to avoid accumulation.
Codeine: 2.5-3.5 hours (neonates: 4.5 hours); Promethazine: 9-16 hours (metabolites up to 24 hours); Phenylephrine: 2-3 hours (oral) or 30-60 minutes (IV).
Primarily renal (approximately 80%) as inactive metabolites, with about 20% eliminated via feces. Less than 10% excreted unchanged.
Codeine: renal (10-30% unchanged, 40-70% as codeine-6-glucuronide, 5-15% as morphine and norcodeine conjugates); Promethazine: renal (70-80% as metabolites); Phenylephrine: renal (80-90% unchanged and as sulfate conjugates).
Category C
Category D/X
Opioid Agonist
Opioid Agonist